PURPOSE: This study examined the relationships between physical symptoms, self-efficacy for coping with symptoms, and functional, emotional, and social well-being in women who were taking adjuvant endocrine therapy for breast cancer. METHODS: One hundred and twelve women who were taking adjuvant endocrine therapy (tamoxifen or an aromatase inhibitor) for breast cancer completed measures of physical symptoms, self-efficacy for coping with symptoms, and functional, social, and emotional well-being at the time of routine medical follow-up (women were on average 3.4 years post-surgery; range 3 months to 11 years). RESULTS: Multiple linear regression analyses showed that higher self-efficacy for coping with symptoms was associated with greater functional, emotional, and social well-being after controlling for physical symptoms (p < 0.05). Self-efficacy for coping with symptoms moderated the relationship between physical symptoms and functional (B = 0.05, SE = 0.02, t = 2.67, p = 0.009) and emotional well-being (B = 0.03, SE = 0.01, t = 2.45, p = 0.02). As self-efficacy increased, the relationship between greater physical symptoms and lower well-being became weaker. Among women with high levels of self-efficacy, physical symptoms were not related to functional and emotional well-being. CONCLUSIONS: Self-efficacy for coping with symptoms may reduce the negative impact of physical symptoms and contribute to well-being in breast cancer survivors taking adjuvant endocrine therapy. Future studies could examine whether psychosocial interventions aimed at increasing self-efficacy for managing symptoms help women better cope with treatment side effects and improve quality of life.
PURPOSE: This study examined the relationships between physical symptoms, self-efficacy for coping with symptoms, and functional, emotional, and social well-being in women who were taking adjuvant endocrine therapy for breast cancer. METHODS: One hundred and twelve women who were taking adjuvant endocrine therapy (tamoxifen or an aromatase inhibitor) for breast cancer completed measures of physical symptoms, self-efficacy for coping with symptoms, and functional, social, and emotional well-being at the time of routine medical follow-up (women were on average 3.4 years post-surgery; range 3 months to 11 years). RESULTS: Multiple linear regression analyses showed that higher self-efficacy for coping with symptoms was associated with greater functional, emotional, and social well-being after controlling for physical symptoms (p < 0.05). Self-efficacy for coping with symptoms moderated the relationship between physical symptoms and functional (B = 0.05, SE = 0.02, t = 2.67, p = 0.009) and emotional well-being (B = 0.03, SE = 0.01, t = 2.45, p = 0.02). As self-efficacy increased, the relationship between greater physical symptoms and lower well-being became weaker. Among women with high levels of self-efficacy, physical symptoms were not related to functional and emotional well-being. CONCLUSIONS: Self-efficacy for coping with symptoms may reduce the negative impact of physical symptoms and contribute to well-being in breast cancer survivors taking adjuvant endocrine therapy. Future studies could examine whether psychosocial interventions aimed at increasing self-efficacy for managing symptoms help women better cope with treatment side effects and improve quality of life.
Authors: Emily J Bartley; Sara N Edmond; Anava A Wren; Tamara J Somers; Irene Teo; Sicong Zhou; Krista A Rowe; Amy P Abernethy; Francis J Keefe; Rebecca A Shelby Journal: J Pain Symptom Manage Date: 2014-02-13 Impact factor: 3.612
Authors: Nicole Hochhausen; Elizabeth M Altmaier; Richard McQuellon; Stella M Davies; Esperanza Papadopolous; Shelly Carter; Jean Henslee-Downey Journal: J Psychosoc Oncol Date: 2007
Authors: Sharon L Manne; Deborah A Kashy; David W Kissane; Melissa Ozga; Shannon Myers Virtue; Carolyn J Heckman Journal: Support Care Cancer Date: 2019-08-01 Impact factor: 3.603
Authors: Adrian N S Badana; Victoria R Marino; Maureen E Templeman; Susan C McMillan; Cindy S Tofthagen; Brent J Small; William E Haley Journal: Support Care Cancer Date: 2019-03-08 Impact factor: 3.603
Authors: Andrea Sitlinger; Rebecca A Shelby; Alyssa N Van Denburg; Heidi White; Sarah N Edmond; Paul K Marcom; Hayden B Bosworth; Francis J Keefe; Gretchen G Kimmick Journal: J Geriatr Oncol Date: 2018-12-13 Impact factor: 3.599
Authors: Rebecca A Shelby; Caroline S Dorfman; Hayden B Bosworth; Francis Keefe; Linda Sutton; Lynda Owen; Leonor Corsino; Alaattin Erkanli; Shelby D Reed; Sarah S Arthur; Tamara Somers; Nadine Barrett; Scott Huettel; Juan Marcos Gonzalez; Gretchen Kimmick Journal: Contemp Clin Trials Date: 2018-11-22 Impact factor: 2.226
Authors: Caroline S Dorfman; Sarah S Arthur; Gretchen G Kimmick; Kelly W Westbrook; Paul Kelly Marcom; Cheyenne Corbett; Sara N Edmond; Rebecca A Shelby Journal: Menopause Date: 2019-08 Impact factor: 2.953
Authors: Jamie M Jacobs; Kathryn Post; Katina Massad; Nora K Horick; Emily A Walsh; Julia Cohn; Chelsea S Rapoport; Amy J Clara; Michael H Antoni; Steven A Safren; Ann H Partridge; Jeffrey M Peppercorn; Elyse R Park; Jennifer S Temel; Joseph A Greer Journal: Cancer Date: 2022-08-04 Impact factor: 6.921
Authors: Blanca Noriega Esquives; Tae K Lee; Patricia I Moreno; Rina S Fox; Betina Yanez; Gregory E Miller; Ryne Estabrook; Mark J Begale; Sarah C Flury; Kent Perry; Shilajit D Kundu; Frank J Penedo Journal: J Behav Med Date: 2022-02-02